Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic tes... read more Featured Products: More products

Download Mobile App




Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

By LabMedica International staff writers
Posted on 10 Apr 2025

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies, have entered into a strategic collaboration to develop and commercialize a seamless end-to-end workflow that combines Cepheid's GeneXpert system for pre-sequencing sample and library preparation with Oxford Nanopore's rapid, information-rich molecular analysis platform. More...

The two companies have completed a successful proof-of-concept study which demonstrated the feasibility of using Cepheid's cartridge-based GeneXpert system for sample and library preparation in a workflow with Oxford Nanopore's sequencing platform. The positive results from the proof-of-concept have paved the way for the strategic collaboration to develop and launch a joint Research Use Only (RUO) workflow that will enable customers to leverage rapid, information-rich sequencing in-house for infectious disease analysis, returning results within hours instead of days. The initial application of the workflow will focus on infectious disease, specifically the profiling of bacterial and fungal pathogens with whole genome sequencing first from culture isolates and eventually directly from positive blood cultures. The collaboration has the potential to expand from this initial application into additional infectious disease use cases, other areas such as cancer and human genetics, and eventually regulatory approved clinical diagnostics.

The collaboration is intended to deliver a scalable, automated, end-to-end solution for simplified nanopore sequencing workflows for use within a range of settings, including labs that have previously not had the expertise to conduct sequencing in-house. The joint workflow will be compatible with a range of third-party informatics tools including Oxford Nanopore's EPI2ME, and other informatic solutions that are part of Oxford Nanopore's compatible provider network. Cepheid will also complement the joint workflow by directly offering an informatics solution, which they will commercialize by way of a license from a leading industry player; this informatics platform provides comprehensive pathogen identification, comprehensive antimicrobial resistance gene detection, SNP-based clonality for outbreak tracking and surveillance, and AI-driven genotypic antimicrobial susceptibility predictions.

"Combining the ease-of-use of the GeneXpert system, the most widely placed PCR diagnostic instrument world-wide, with Oxford Nanopore's unique sequencing platform, unlocks a richness of biomarker data that has historically been technically challenging for many labs to access," said Vitor Rocha, President of Cepheid. "Providing an integrated solution to more effectively characterize infectious diseases, understand the epidemiology of bacterial outbreaks, and profile antimicrobial resistance will meaningfully accelerate our mission of expanding access to critical molecular information. The potential for future expansion of this technology to applications for patient care is exciting."

"This collaboration represents an important step forward in delivering new and improved workflow options to better understand infectious diseases," added Dr. Gordon Sanghera, CEO of Oxford Nanopore Technologies. "By partnering to integrate our richer data, rapid insights, and accessible and affordable sequencing technology with Cepheid's GeneXpert architecture, we are establishing a workflow foundation that is positioned for future expansion into scaled routine clinical use."


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Hematology System
Medonic M16C
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.